# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-23-052112
Filing Date
2023-04-28
Accepted
2023-04-28 08:02:13
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm237755d2_ars.pdf | ARS | 1551326
| Complete submission text file | 0001104659-23-052112.txt |  | 2138112

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39202 | Film No.: 23860275
SIC: 2834 Pharmaceutical Preparations